Journal
NATURE
Volume 464, Issue 7291, Pages 993-998Publisher
NATURE PORTFOLIO
DOI: 10.1038/nature08987
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA127003-04, P01 CA117969, P50 CA102701, R21 CA094510, P50 CA127003, P01 CA117969-05, P01 CA117969-04S1, P50 CA102701-08, P50 CA127003-05] Funding Source: Medline
- NHGRI NIH HHS [R01 HG001806-02] Funding Source: Medline
- NIDDK NIH HHS [K08 DK071329, K08 DK071329-05, K08 DK071329-04] Funding Source: Medline
- Wellcome Trust [093867, 088340, 077198] Funding Source: Medline
- Grants-in-Aid for Scientific Research [20221009] Funding Source: KAKEN
Ask authors/readers for more resources
The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
